Research Uncovers Potential Preventative for Central Line Infection
News Sep 17, 2013
Earlier research by Hostetter’s team showed that heparin, when fed through central lines to prevent clotting, binds with the Candida albicans yeast that lives on and in all of us. Candida uses the binding to elude the body’s immune response and to form biofilms – communities of microorganisms that grow on the inside surface of the catheters. Biofilms are the first step in bloodstream infections with the yeast.
Hostetter and her team developed an antibody that prevents Candida albicans from binding with heparin and thereby stops biofilm formation in a rat model of catheter-associated infection.
“Understanding how the medications in catheters facilitate biofilm formation by microbes can lead to new strategies for prevention of line infections,”says Hostetter.
Her collaborators on the study included researchers from Duke University Medical Center, the University of Cincinnati, and the University of Wisconsin. When the antibody is modified to be compatible with humans, clinical trials of the treatment can begin in humans.
Strong Immune Response Linked to Stunted Growth in ChildrenNews
An overactive immune system during childhood among young people in Ecuador’s indigenous Shuar population comes with a cost: stunted growth.READ MORE
Flavins Keep a Handy Helper in Their PocketNews
A team has now shown in detail how oxygen interacts with the flavin in an enzyme - revealing for the first time precisely how it works. Flavins play a key role in metabolic processes, in the immune system and in neural development in humans - and are equally important to bacteria, fungi and plants.READ MORE
Comments | 0 ADD COMMENT
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018